Autologous muscle-derived cells (JPN1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous muscle-derived cells (JPN1), covering 2024-08-27 to 2024-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1) [Phase 3]